TNF/IFN-γ-IN-1

Overview

TNF/IFN-γ-IN-1 (compound TGA) is a dual inhibitor of TNF and IFN-γ . TNF/IFN-γ-IN-1 can used in study Alzheimer’s disease.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > IFNAR

Product Information

• Catalog No.: HY-161016
• CAS No.: 876013-29-5
• Molecular Formula: C20H23N3O6
• Molecular Weight: 401.41
• Purity: 99.39%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (12.46 mM); Clear solution
• Availability: In-stock

Source

Original product source